The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the time of their initial surgery. However, higher age was ...
An adenomatous polyp in which malignant cells have invaded beyond the muscularis mucosa into the submucosa may still be curable by colonoscopic polypectomy under specific conditions, depending on the ...
Underinvested, Under-Referred, and Underserved: Applying a Gender Equity Continuum Framework in Cancer Control Continuum Programs and Policies to Expand to Transgender and Nonbinary Populations Of 336 ...
On Saturday, Amgen Inc (NASDAQ:AMGN) and AstraZeneca Plc (NASDAQ:AMGN) announced full results from the Phase 3, registrational WAYPOINT trial evaluating the efficacy and safety of tezepelumab in ...
SAN DIEGO -- Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for further treatments, the WAYPOINT trial showed. The monoclonal ...
Findings showed treatment with tezepelumab significantly reduced the size of nasal polyps and nasal congestion compared with placebo. The Food and Drug Administration (FDA) has approved Tezspire ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results